Vanguard holds 8.55% of Eli Lilly, 80,952,595 shares (LLY)
The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of Eli Lilly (LLY) common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of Eli Lilly (LLY) common stock. As of 09/30/2025, Vanguard reported 80,952,595 shares, representing 8.55% of the class. Vanguard is identified as an investment adviser and certified the holdings were acquired and are held in the ordinary course, not to change or influence control.
The filing details 0 shares with sole voting power and 4,843,238 shares with shared voting power. Vanguard reported 73,223,987 shares with sole dispositive power and 7,728,608 shares with shared dispositive power. The filing also notes that Vanguard’s clients have rights to dividends or sale proceeds, and no single other person’s interest exceeds 5%.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Eli Lilly (LLY) does The Vanguard Group report?
What is the filing type and purpose for LLY?
What is the event date tied to Vanguard’s LLY ownership report?
AI-generated analysis. How Rhea-AI works. Not financial advice.